July 18, 2002 — A report issued by Cambridge Healthtech Institute states that the DNA microarray market has become increasingly competitive but forecasts that the market will nevertheless remain viable.

The report, titled “Outlook for DNA Microarrays: Emerging Applications and Insights on Optimizing Microarray Studies,” costs $1,250.

It maintains it is unlikely that comprehensive protein arrays will be widely launched and adopted over the next two years, and that it appears unlikely protein arrays will be competitive with gene arrays in that time frame. However, it acknowledges that researchers will increasingly turn to protein arrays as the technology advances, and suggests they may employ a two-tiered strategy that employs both types of arrays.